H. Claman

发表

Thymus-Marrow Cell Combinations. Synergism in Antibody Production.∗

H. Claman, E. Chaperon, R. Triplett, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Suppressive Mechanisms Involving Sensitization and Tolerance in Contact Allergy

S. Miller, M. Sy, S. Miller, 1980, Immunological reviews.

T-cell tolerance—One signal?

H. Claman, 1979 .

T cell signals: tolerance to DNFB is converted to sensitization by a separate nonspecific second signal.

H. Claman, R. Cleveland, 1980, Journal of immunology.

Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells".

H. Claman, H N Claman, K L Choi, 1986, Journal of immunology.

Morphological evidence for chronic mast cell activation after prolonged exposure with supernatants from chronic graft-versus-host splenocytes.

F. Levi-Schaffer, I. Hammel, H. Claman, 1991, Immunology letters.

Immunoglobulin dysregulation in murine graft-vs-host disease: a hyper-IgE syndrome.

H. Claman, H. Spiegelberg, 1990, Clinical immunology and immunopathology.

More about mast cells and fibrosis in porphyria cutanea tarda

H. Claman, 1990, Hepatology.

Histamine release from mouse and rat mast cells cultured with supernatants from chronic murine graft-vs-host splenocytes.

F. Levi-Schaffer, H. Claman, Y. Mekori, 1990, Cellular immunology.

Mast cell changes in a case of rapidly progressive scleroderma-ultrastructural analysis.

H. Claman, 1989, The Journal of investigative dermatology.

On scleroderma. Mast cells, endothelial cells, and fibroblasts.

H. Claman, 1989, JAMA.

Mast cells, fibroblasts, and fibrosis

H. Claman, K. L. Choi, Henry N. Claman, 1987, Immunologic research.

Simultaneous in situ detection of IgE receptors and cytoplasmic granules in murine cutaneous mast cells.

H. Claman, K. L. Choi, R. Giorno, 1987, Journal of immunological methods.

Characterization of the immunosuppressive effect of burned tissue in an animal model.

J. Hansbrough, J. Boswick, H. Claman, 1984, The Journal of surgical research.

Immunologic Complementation between Thymus and Marrow Cells—A Model for the Two‐Cell Theory of Immunocompetence

H. Claman, E. Chaperon, 1969, Transplantation reviews.

Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide.

M. Sy, S. Miller, H. Claman, 1977, Journal of immunology.

Suppression of cytotoxic T-cell generation by natural suppressor cells from mice with GVHD is partially reversed by indomethacin.

H. Claman, K. L. Choi, T. Maier, 1988, Cellular immunology.

David W. Talmage, 1919–2014

J. Cambier, H. Claman, P. Marrack, 2014, Proceedings of the National Academy of Sciences.

Dyspnea and pulmonary infiltrates in a 53-year-old woman with common variable immunodeficiency.

S. Dreskin, H. Claman, D. A. Dibbern, 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Immunological tolerance to self and non-self.

H. Claman, J. Battisto, D. Scott, 1982, Annals of the New York Academy of Sciences.

Systemic (allergic?) vasculitis.

E. Thorne, H. Claman, R. Stanford, 1974, The Journal of allergy and clinical immunology.

Introduction to the article by Kastin et al. on some principles in the peptide field: Possible considerations for immunology

H. Claman, 1987 .

Allergic and nonallergic factors in upper and lower airway disease.

H. Claman, 1986, Cleveland Clinic quarterly.

The New Cellular Immunology

H. Claman, 1973 .

Mast cell immunohistochemistry: non-immunological immunostaining mediated by non-specific F(ab′)2-mast cell secretory granule interaction

H. Claman, R. Giorno, P. Schiltz, 1993, The Histochemical Journal.

Progressive myocardial damage following recovery from diphtheria. A case showing development of complete heart block.

H. Claman, 1962, The American journal of cardiology.

H. Claman, C. Walters, 1975, Journal of immunology.

Antinuclear antibodies and breast implants.

H. Claman, A. D. Robertson, 1994, The Western journal of medicine.

Immunologic dysfunction in scleroderma: evidence for increased mast cell releasability and HLA-DR positivity in the dermis.

J. Huff, H. Claman, R. Giorno, 1988, Arthritis and rheumatism.

Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems.

B. Jaffee, H. Claman, Henry N. Claman, 1983, Cellular immunology.

Asthma and immunological diseases in pregnancy and early infancy

R. Zeiger, M. Schatz, H. Claman, 1998 .

Maternal Immune Responses Affecting Pregnancy and the Fetus

H. Claman, 1993 .

Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin".

J. Seibold, H. Claman, R. Giorno, 2010, Arthritis and rheumatism.

QUANTITATIVE MEASUREMENT OF HUMAN GAMMA-2, BETA-2A, AND BETA-2M SERUM IMMUNOGLOBULINS.

D. Merrill, H. Claman, 1964, The Journal of laboratory and clinical medicine.

How corticosteroids work.

H. Claman, 1975, The Journal of allergy and clinical immunology.

Carotid body resectionApproved by the executive committee of the American academy of allergy and immunology

W. Pierson, P. Lieberman, A. Sheffer, 1986 .

Pregnancy and immunology: selected aspects.

H. Claman, G. W. Palmer, G. Palmer, 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Current issues relating to in vitro testing for allergen-specific IgE: a workshop report.

W. Dolen, T. Platts-Mills, S. Ahlstedt, 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Dermal mast cell degranulation in systemic sclerosis.

J. Seibold, H. Claman, R. Giorno, 1990, Arthritis and rheumatism.

Hypogammaglobulinemia, primary and secondary: Immunoglobulin levels (γG, γA, γM) in one hundred and twenty-five patients

D. Merrill, H. Claman, T. Hartley, 1966 .

The effect of histamine receptor antagonists on specific and nonspecific suppression of experimental contact sensitivity.

J. Hansbrough, H. Claman, Y. Mekori, 1985, The Journal of allergy and clinical immunology.

Control of experimental contact sensitivity.

S. Miller, S. Miller, P. Conlon, 1980, Advances in immunology.

Efficient induction of immediate tolerance to contact sensitivity by hapten-modified spleen cells requires Ia+ cells compatible with recipient

P. Conlon, H. Claman, J. Moorhead, 1979, Nature.

“SIGNAL THEORY” IN CELLULAR IMMUNOLOGY: COLLABORATION BETWEEN T‐ AND B‐LYMPHOCYTES IN THE IMMUNE RESPONSE

H. Claman, 1975, Annals of the New York Academy of Sciences.

CURRENT CONCEPTS IN CELLULAR IMMUNOLOGY

H. Claman, 1975 .

The induction of tolerance to DNFB contact sensitivity using hapten modified lymphoid cells. I. Cellular requirements for rapid induction of tolerance.

P. Conlon, H. Claman, J. Moorhead, 1980, Cellular immunology.

Natural suppressor activity in graft-vs-host spleen and normal bone marrow is augmented by IL 2 and interferon-gamma.

H. Claman, T. Maier, J. Holda, 1986, Journal of immunology.

Natural suppressor (NS) cells members of the LGL regulatory family.

H. Claman, T. Maier, J. Holda, 1986, Immunology today.

Members of the LGL regulatory family

H. Claman, T. Maier, J. Holda, 1986 .

Synergism between T and non-T cells in the in vivo induction and in vitro expression of graft-vs.-host disease-induced natural suppressor cells

H. Claman, T. Maier, J. Holda, 1985, The Journal of experimental medicine.

Mast cell depletion in murine chronic graft-versus-host disease.

H. Claman, 1985, The Journal of investigative dermatology.

Corticosteroids and the immune response.

H. Claman, 1988, Advances in experimental medicine and biology.

Cell-cell interactions in antibody production.

D. Mosier, H. Claman, 1972, Progress in allergy.

Anti-inflammatory Effects of Corticosteroids

H. Claman, 1984, Clinics in Immunology and Allergy.

The induction of tolerance to DNFB contact sensitivity by using hapten-modified lymphoid cells. III. Effects of hapten concentration on the ability of MLS-disparate cells to induce rapid unresponsiveness.

S. Miller, P. Conlon, H. Claman, 1980, Journal of immunology.

Mast cells, T cells and abnormal fibrosis.

H. Claman, 1985, Immunology today.

The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells

S. Miller, H. Claman, R. Wetzig, 1979, The Journal of experimental medicine.

Immunology of pregnancy

J. Poole, H. Claman, 2004, Clinical reviews in allergy & immunology.

Unproven procedures for diagnosis and treatment of allergic and immunologic diseases: Approved by the executive committee of the American academy of allergy and immunology

W. Pierson, A. Sheffer, R. Slavin, 1986 .

Vasculitis in chronic urticaria.

P. Phanuphak, H. Claman, R. Stanford, 1980, The Journal of allergy and clinical immunology.

Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response.

H. Weiner, H. Claman, J. Moorhead, 1976, Journal of immunology.

Amyloid-associated muscle pseudohypertrophy.

H. Claman, S. Ringel, 1982, Archives of neurology.

Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts. American Academy of Allergy and Immunology.

W. Pierson, A. Sheffer, R. Slavin, 1986, The Journal of allergy and clinical immunology.

IL-3, IL-4, and IL-6 enhance IFN-γ-dependent bone marrow natural suppressor activity☆

H. Claman, T. Maier, J. Holda, 1990 .

Natural suppressor cells.

H. Claman, T. Maier, J. Holda, 1989, Progress in clinical and biological research.

Corticosteroids and lymphoid cells in vitro. I. Hydrocortisone lysis of human, guinea pig, and mouse thymus cells.

H. Claman, J. Moorhead, W. Benner, 1971, The Journal of laboratory and clinical medicine.

Glucocorticosteroids I: anti-inflammatory mechanisms.

H. Claman, 1983, Hospital practice.

Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.

H. Claman, T. Maier, J. Holda, 1985, Journal of immunology.

Hydrocortisone Resistance of Graft vs Host Activity in Mouse Thymus, Spleen and Bone Marrow

J. Cohen, M. Fischbach, H. Claman, 1970, The Journal of Immunology.

Corticosteroids in inflammatory bowel disease. A review.

H. Claman, J. Routes, 1987, Journal of clinical gastroenterology.

Characterization and Functions of the Natural Suppressor Cell Systems

H. Claman, K. Choi, T. Maier, 1989 .

Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen

S. Miller, M. Sy, S. Miller, 1979, The Journal of experimental medicine.

The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction.

S. Miller, S. Miller, H. Claman, 1976, Journal of immunology.

Monoclonal antibody analysis of skin in chronic murine graft vs host disease produced across minor histocompatibility barriers.

H. Claman, H. Katz, K. L. Choi, 1987, Cellular immunology.

Is graft-versus-host disease a reliable model for scleroderma?

H. Claman, Y. Mekori, Henry N. Claman, 1986, La Ricerca in clinica e in laboratorio.

Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies.

E. Thorne, H. Claman, W. M. Sams, 1977, The Journal of investigative dermatology.

Thymus and X-radiation in the Termination of Acquired Immunological Tolerance in the Adult Mouse

H. Claman, Wendy T. McDonald, 1964, Nature.

TOLERANCE TO A PROTEIN ANTIGEN IN ADULT MICE AND THE EFFECT OF NONSPECIFIC FACTORS.

H. Claman, 1963, Journal of immunology.

Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease.

C. Howell, H. Claman, J. Vierling, 1989, Journal of immunology.

Regulation of cell mediated immunity by antibodies: possible role of anti-receptor antibodies in the regulation of contact sensitivity to DNFB in mice.

M. Sy, H. Claman, J. Moorhead, 1979, Journal of immunology.

Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells".

H. Claman, J. Moorhead, P. Phanupak, 1974, Journal of immunology.

The remote practice of allergy

W. Pierson, A. Sheffer, R. Slavin, 1986 .

Materno-Fetal Relationships

H. Claman, 1993 .

Human necrotizing vasculitis: immunoglobulins and complement in vessel walls of cutaneous lesions and normal skin.

H. Claman, P. Small, R. Mcintosh, 1975, The Journal of investigative dermatology.

CSF immunoglobulins in multiple sclerosis and other neurologic diseases. Measurement by electroimmunodiffusion.

H. Claman, S. Schneck, 1969, Archives of neurology.

Quantitation of immunoglobulins in cerebrospinal fluid.

D. Merrill, H. Claman, T. Hartley, 1966, Archives of neurology.

Propyl gallate-contact sensitization and orally-induced tolerance.

P. Phanuphak, G. Kahn, H. Claman, 1974, Archives of dermatology.

Mechanism of cortisol inhibition of adoptive transfer of tuberculin sensitivity.

G. Krueger, W. Weston, H. Claman, 1973, The Journal of laboratory and clinical medicine.

Site of action of cortisol in cellular immunity.

G. Krueger, W. Weston, H. Claman, 1973, Journal of immunology.

Corticosteroids and lymphoid cells.

H. Claman, 1972, The New England journal of medicine.

T CELL SIGNALS IN TOLERANCE *

H. Claman, 1982, Annals of the New York Academy of Sciences.

Differential suppressive effect of hydrocortisone on lymphocytes and mononuclear macrophages in delayed hypersensitivity of guinea pigs.

G. Krueger, W. Weston, H. Claman, 1972, The Journal of investigative dermatology.

The induction of hapten‐specific T cell tolerance using hapten‐modified lymphoid membranes II. Relative roles of suppressor T cells and clone inhibition in the tolerant state

S. Miller, H. Claman, M. Sy, 1977, European journal of immunology.

THYMUS-MARROW IMMUNOCOMPETENCE : V. HYDROCORTISONE-RESISTANT CELLS AND PROCESSES IN THE HEMOLYTIC ANTIBODY RESPONSE OF MICE

J. Cohen, H. Claman, 1971 .

THYMUS-MARROW IMMUNOCOMPETENCE

J. Cohen, H. Claman, B. J. J. Cohen, 1971, The Journal of experimental medicine.

Salivary Immunoglobulins: Absence of γA in Saliva Following Exchange Transfusions in Neonatal Period

D. Merrill, H. Claman, J. Selner, 1967, Pediatrics.

Electroimmunodiffusion (EID): a simple, rapid method for quantitation of immunoglobulins in dilute biological fluids.

D. Merrill, H. Claman, T. Hartley, 1967, The Journal of laboratory and clinical medicine.

Thymus-Marrow Immunocompetence III. The Requirement for Living Thymus Cells∗

H. Claman, E. Chaperon, J. Selner, 1968 .

THE EFFECT OF ENDOTOXIN ON THE THYMUS OF YOUNG MICE.

H. Claman, P. Kind, D. Rowlands, 1965, The American journal of pathology.

THYMECTOMY: PROLONGATION OF IMMUNOLOGICAL TOLERANCE IN THE ADULT MOUSE.

H. Claman, D W TALMAGE, H N CLAMAN, 1964, Science.

Maternal Immunocompetence During Pregnancy

H. Claman, 1993 .

Maternal Immune Responses to Fetal Antigens

H. Claman, 1993 .

The Immunology of Human Pregnancy

H. Claman, 1993, Humana Press.

Recurrent Pregnancy Loss

H. Claman, 1993 .

Human Thymus Cell Cultures—Evidence for Two Functional Populations.∗

H. Claman, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

The biology of the immune response.

H. Claman, 1987, JAMA.

Effects of phytohemagglutinin on humoral antibody response, delayed hypersensitivity, and homograft rejection.

T. Starzl, R. N. Macsween, N. Kashiwagi, 1970, Surgery.

IMMUNOLOGIC REACTIONS TO HAPTENS ON AUTOLOGOUS CARRIERS : I. PARTICIPATION OF BOTH THYMUS-DERIVED AND BONE MARROW-DERIVED CELLS IN THE SECONDARY IN VITRO RESPONSE

H. Claman, J. Moorhead, C. Walters, 1973 .

Salivary immunoglobulins: normal adult values and dissociation between serum and salivary levels.

D. Merrill, H. Claman, T. Hartley, 1967, The Journal of allergy.

Diphtheria toxin A gene-mediated HIV-1 protection of cord blood-derived T cells in the SCID-hu mouse model.

E. Shpall, J. Campain, G. Harrison, 1998, Journal of hematotherapy.

Serum immunoglobulin measurement during the first year of life and in immunoglobulin-deficiency states.

D. Merrill, H. Claman, O. Sieber, 1966, The Journal of pediatrics.

Salivary immunoglobulin and albumin: development during the newborn period.

D. Merrill, H. Claman, J. Selner, 1968, The Journal of pediatrics.

Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena.

H. Claman, T. Maier, J. Holda, 1985, Journal of immunology.

Immunocompetence of transferred thymus-marrow cell combinations.

H. Claman, E. Chaperon, R. Triplett, 1966, Journal of immunology.

Thymus-derived lymphocytes and hydrocortisone: identification of subsets of theta-bearing cells and redistribution to bone marrow.

H. Claman, J. Moorhead, 1972, Cellular immunology.

Isolated severe gamma A deficiency: immunoglobulin levels, clinical disorders, and chromosome studies.

D. Peakman, A. Robinson, D. Merrill, 1970, The Journal of laboratory and clinical medicine.

New hope for neurofibromatosis? The mast cell connection.

H. Claman, 1987, JAMA.

Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA.

J. Portanova, B. Kotzin, H. Claman, 1985, Journal of immunology.

Postburn immunosuppression in an animal model. II. Restoration of cell-mediated immunity by immunomodulating drugs.

J. Hansbrough, H. Claman, V. Peterson, 1984, Surgery.

TOLERANCE TO CONTACT SENSITIVITY--A ROLE FOR SUPPRESSOR T CELLS?

P. Phanuphak, H. Claman, J. Moorhead, 1974 .

Silicone Breast Implants, Chronic Fatigue Syndrome and Fibromyalgia

P. Levine, D. Clauw, H. Claman, 2000 .

Histiocytic reaction in dysgammaglobulinemia and congenital rubella.

V. Suvatte, J. Githens, H. Claman, 1970, Pediatrics.

Suppressor T cell circuits in contact sensitivity. I. Two mechanistically distinct waves of suppressor T cells occur in mice tolerized with syngeneic DNP-modified lymphoid cells.

L. Butler, S. Miller, H. Claman, 1982, Journal of immunology.

Suppressor T cell mechanisms in contact sensitivity. II. Afferent blockade by alloinduced suppressor T cells.

M. Sy, S. Miller, H. Claman, 1978, Journal of immunology.

Tolerance and contact sensitivity to DNFB in mice. V. Induction of tolerance with DNP compounds and with free and membrane-associated DNFB.

H. Claman, 1976, Journal of immunology.

Suppressor cells in tolerance to contact sensitivity active against hapten-syngeneic and hapten-allogeneic determinants

M. Sy, S. Miller, H. Claman, 1977, The Journal of experimental medicine.

IMMUNITY AND TOLERANCE TO A HAPTEN (NIP) COUPLED TO AN ISOLOGOUS CARRIER (MOUSE GAMMA GLOBULIN)

H. Claman, J. Moorhead, C. Walters, 1972, The Journal of experimental medicine.

Immunoregulation of contact sensitivity.

S. Miller, H. Claman, 1980, The Journal of investigative dermatology.

T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.

L. Butler, S. Miller, H. Claman, 1983, Cellular immunology.

Desensitization of experimental contact sensitivity.

H. Claman, Y. Mekori, 1986, The Journal of allergy and clinical immunology.

The induction of cell-mediated immunity and tolerance to insulin with insulin coupled to syngeneic lymphoid cells.

N. Reiner, H. Claman, 1981, Cellular immunology.

Requirements for induction of T cell tolerance to DNFB: efficiency of membrane-associated DNFB.

S. Miller, H. Claman, 1976, Journal of immunology.

Immunologic reactions to haptens on autologous carriers. II. Induction of hapten-specific tolerance and correlations between antibody response and antigen-driven cell proliferation in vitro.

H. Claman, C. Walters, 1974, Journal of immunology.

Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation.

P. Phanuphak, H. Claman, J. Moorhead, 1974, Journal of immunology.

Bone marrow T cells. II. Thymic dependency.

H. Claman, 1974, Cellular immunology.

Bone Marrow T Cells

H. Claman, 1974, The Journal of Immunology.

Bone marrow T cells. I. Response to the T cell mitogens, phytohemagglutinin and concanavalin A.

H. Claman, 1974, Journal of immunology.

Genetic restrictions for the induction of suppressor T cells by hapten- modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity. Role of the H-2D region of the major histocompatibility complex

M. Sy, S. Miller, H. Claman, 1978, The Journal of experimental medicine.

Unresponsiveness in hapten-specific cytotoxic lymphocytes. III. Influence of H-2 and non-H-2 gene loci on the in vitro trinitrophenyl-specific CTL response following either acute or chronic in vivo treatment with trinitrobenzene sulfonic acid.

L. Butler, S. Miller, J. Chiller, 1983, Cellular immunology.

Unresponsiveness in hapten-specific cytotoxic lymphocytes. II. Ability of various TNP-congeners to induce unresponsiveness after repeated treatments beginning at birth.

L. Butler, S. Miller, H. Claman, 1982, Journal of immunology.

Unresponsiveness in hapten-specific cytotoxic T lymphocytes. I. Characteristics of tolerance induction in adult mice.

L. Butler, S. Miller, H. Claman, 1981, Journal of immunology.

Nature of hapten-modified determinants involved in induction of T cell tolerance and suppressor T cells to NDFB contact sensitivity.

H. Grey, S. Colon, M. Sy, 1980, Journal of immunology.

H-2 restriction of suppressor T-cell induction by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitization

M. Sy, S. Miller, H. Claman, 1977, The Journal of experimental medicine.

Tolerance: two pathways of negative immunoregulation in contact sensitivity to DNFB.

S. Miller, H. Claman, J. Moorhead, 1977, Cold Spring Harbor symposia on quantitative biology.

Experimental production of granulomatous pneumonitis. Comparison of immunological and morphological sequelae with particulate and soluble antigens administered via the respiratory route.

P. Phanuphak, J. Salvaggio, J. Salvaggio, 1975, The Journal of allergy and clinical immunology.

Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa.

H. Claman, R. Stanford, P. Kohler, 1980, The Journal of rheumatology.

Urokinase: Antigenic studies in patients following thrombolytic therapy

E. Genton, H. Claman, 1970 .

IMMUNOLOGIC REACTIONS TO HAPTENS ON AUTOLOGOUS CARRIERS

H. Claman, J. Moorhead, C. Walters, 1973, The Journal of experimental medicine.

IMMUNOLOGIC REACTIONS TO HAPTENS

H. Claman, J. Moorhead, C. Walters, 2003 .

Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.

E. Shpall, H. Claman, M. Bitter, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Changes in serum immunoglobulin and complement levels following renal homotransplantation.

P. Levine, D. Merrill, H. Claman, 1970 .

Murine Graft‐versus‐Host Disease across Minor Barriers: Immunosuppressive Aspects of Natural Suppressor Cells

H. Claman, T. Maier, J. Holda, 1985, Immunological reviews.

Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?

R. Clark, H. Claman, J. Steigerwald, 1985, Annals of internal medicine.

Migration of antibody-forming cells and antigen-sensitive precursors between spleen, thymus and bone marrow.

H. Claman, E. Chaperon, J. Selner, 1968, Immunology.

Autoimmunity after silicone breast implants.

H. Claman, 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Subpopulations of mouse T lymphocytes. I. "Thymidine suicide" of a major proliferating, PHA-responsive cell population present in spleen but not in lymph node.

H. Claman, J. Moorhead, 1974, Journal of immunology.

Tolerance and contact sensitivity to DNFB in mice. II. Specific in vitro stimulation with a hapten, 2,4-dinitrobenzene sulfonic acid (DNB-SO3Na).

P. Phanuphak, H. Claman, J. Moorhead, 1974, Journal of immunology.

PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

H. Claman, 2002 .

Restoration of immunity in burned mice by cimetidine.

J. Hansbrough, H. Claman, R. Zapata-Sirvent, 1985, The Journal of trauma.

The Immune System

Henry N. Claman, H. Claman, 1993 .

Separation of the specific and nonspecific factors in tolerance and immunity. Abstr.

H. Claman, 1963 .

Candidiasis Hypersensitivity Syndrome

W. Pierson, P. Lieberman, A. Sheffer, 1989 .

Candidiasis hypersensitivity syndrome: Approved by the executive committee of the American academy of allergy and immunology

W. Pierson, A. Sheffer, R. Slavin, 1986 .

SYNERGISM BETWEEN T AND NON-T CELLS IN THE VIVO INDUCTION AND IN VITRO EXPRESSION OF GRAFT-VS.-HOST DISEASE-INDUCED NATURAL

H. Claman, T. Maier, J. Holda, 1985 .

Cutaneous mast cell depletion and recovery in murine graft-vs-host disease.

H. Claman, K. L. Choi, R. Giorno, 1987, Journal of immunology.

Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis.

R. Clark, B. Jaffee, J. Huff, 1985, Cellular immunology.

Myelofibrosis and acute lymphoblastic leukemia in a child with Down syndrome

H. Claman, V. Fulginiti, D. Pearlman, 1979 .

Hypergammaglobulinemiathe role of the immunoglobulins (?G, ?A, ?M)

D. Merrill, H. Claman, 1965 .

Natural Suppressor Cell Systems

H. Claman, T. Maier, J. Holda, 1986 .

EVIDENCE THAT IFN‐7 IS RESPONSIBLE FOR NATURAL SUPPRESSOR ACTIVITY IN GVHD SPLEEN AND NORMAL BONE MARROW

H. Claman, T. Maier, J. Holda, 1988, Transplantation.

Anti-Inflammatory Steroid Action: Basic and Clinical Aspects

A. Oronsky, R. Schleimer, H. Claman, 1989 .

DISSOCIATION OF DELAYED-HYPERSENSITIVITY AND ANTIBODY-SYNTHESISING CAPACITIES IN MAN

W. Blackburn, J. Githens, H. Claman, 1966 .

Glucocorticosteroids II: the clinical responses.

H. Claman, 1983, Hospital practice.

Desensitization of contact allergy to DNFB in mice. I. Description of a model system.

B. Jaffee, H. Claman, 1983, Journal of Immunology.

Desensitization of contact allergy to DNFB in mice. III. Characteristics of immediate desensitization induced by haptenated spleen cells.

H. Claman, Y. Mekori, 1986, Cellular immunology.

Desensitization of contract allergy to 2,4-dinitro-1-fluorobenzene in mice. II. Characteristics of "immediate" desensitization.

H. Claman, Y. Mekori, 1984, Cellular immunology.

Induction of tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity with hapten-modified lymphoid cells. II. Selective tolerance in F1 mice of T cell subsets recognizing 1-fluoro-2,4- dinitrobenzene associated with parental major histocompatibility complex antigens

S. Miller, P. Conlon, H. Claman, 1980, The Journal of experimental medicine.

Antinuclear antibodies in apparently healthy women with breast implants.

H. Claman, A. D. Robertson, 1996, Current topics in microbiology and immunology.

Thoreau's natural pollinometers.

H. Claman, 1988, The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha.

Thymectomy: Prolongation of Immunological Tolerance in the Adult Mouse

H. Claman, D. Talmage, 1963, Science.

A splenic requirement for the generation of suppressor T cells.

M. Sy, S. Miller, H. Claman, 1977, Journal of immunology.

IMMUNOGLOBULIN COMPONENTS OF "GAMMA" GLOBULIN IN HUMAN SERUM.

D. Merrill, H. Claman, V. Trevorrow, 1965, Clinical chemistry.

Bone Marrow and Spleen: Dissociation of Immunologic Properties by Cortisone

H. Claman, Mark A. Levine, 1970, Science.

Mast cells and fibrosis. The relevance to scleroderma.

H. Claman, 1990, Rheumatic diseases clinics of North America.

Production of tolerance in immunized mice and the effects of immunosuppression.

E. Bronsky, H. Claman, 1966, The Journal of allergy.

Immunocompetence of transferred thymus-marrow cell combinations. J Immunol 97;6:828-32, 1966.

H. Claman, E. Chaperon, R. Triplett, 2004, Journal of immunology.

Clinical ecology: Approved by the executive committee of the American academy of allergy and immunology

W. Pierson, A. Sheffer, R. Slavin, 1986 .

ANNALS BY VOLUME

J. Volanakis, H. Claman, 1985 .

Serum immunoglobulins in rheumatoid arthritis.

D. Merrill, H. Claman, 1966, The Journal of laboratory and clinical medicine.

On Discovering Thymus–Marrow Synergism

H. Claman, 2014, Front. Immunol..

Pretreatment with minor histocompatibility antigens prevents the development of functional CTL helper cell activity.

H. Claman, R. Hayes, 1983, Journal of immunology.

Murine natural suppressor cells in the newborn, in bone marrow, and after cyclophosphamide. Genetic variations and dependence on IFN-gamma.

H. Claman, T. Maier, J. Holda, 1989, Journal of immunology.

Mast cells and fibrosis. Hints from graft-versus-host disease and scleroderma

H. Claman, 1993 .

Inhibition of antibody production and acquired immunologic tolerance by actinomycin.

E. Bronsky, H. Claman, 1965, Journal of Immunology.

Ultrastructural evidence for mast cell activation in a case of neurofibromatosis.

H. Claman, R. Giorno, J. Lieber, 1989, Neurofibromatosis.

Mast cells and neurofibromatosis.

H. Claman, R. Giorno, 1988, Neurofibromatosis.

Hydrocortisone Resistance of Activated Initiator Cells in Graft versus Host Reactions

H. Claman, J. Cohen, J. Cohen, 1971, Nature.

Modulation of suppressor cell activity and improved resistance to infection in the burned mouse.

J. Hansbrough, H. Claman, V. Peterson, 1985, The Journal of burn care & rehabilitation.

Book ReviewBasic Immunology: Immune mechanisms in health and disease

H. Claman, 1988 .

Does injection therapy produce tolerance or immunity?: Hyposensitization considered as the production of specific acquired tolerance

H. Claman, 1964 .

THYMUS-MARROW IMMUNOCOMPETENCE: IV. The Growth and Immunocompetence of Transferred Marrow, Thymus, and Spleen Cells in Parent and F1 Hybrid Mice

H. Claman, E. Chaperon, L. Hayes, 1969, Transplantation.

Mast Cells and Scleroderma-Reply

H. Claman, 1990 .